Alzheimer’s: Scientists Say We Are at a Turning Point

In the United States today, about one in every three people above 85 years old is living with Alzheimer’s disease. This is according to the National Institute on Ageing. Alzheimer’s is a brain condition that causes slow memory loss and confusion, and it can make life very hard for both patients and their families. The disease takes years to develop, and currently, there is no total cure.

Nevertheless, scientists say something big is happening in the fight against Alzheimer’s. Professor Amy Arnsten of Yale University, together with other researchers from different parts of the world, has given an important update. Writing in the journal Alzheimer’s & Dementia, the team shared new ideas and discoveries, especially about treating the disease in its early stages.

Professor Arnsten explained that Alzheimer’s can be triggered by many things. Sometimes, it is caused by proteins that build up in the brain. Other times, it is because of inflammation — when the brain reacts as if it is fighting an injury or sickness. These changes slowly damage brain cells and lead to memory loss. “We are at a tipping point. We now have the first treatments for Alzheimer’s, but they are not perfect. We must keep going until we have medicines that work better and with fewer side effects,” Arnsten said.

At the moment, two approved antibody treatments can remove one of the main proteins linked to Alzheimer’s. These drugs can slow down the disease but cannot stop it completely, and they do not work for everyone. They can also cause serious side effects.

One reason Alzheimer’s is becoming more common is that people are living longer. Ageing is the most significant risk factor for Alzheimer’s and other kinds of dementia. Sometimes these brain diseases even mix, making them harder to treat. The scientists believe the best hope is to treat the disease early — even before symptoms show. Arnsten’s lab is studying how inflammation damages brain cells and looking for a medicine that can be given safely to people as young as 50 if tests show they are at risk. One exciting breakthrough is a new blood test that can detect signs of Alzheimer’s very early, even before brain scans can see it. This test could help doctors know who needs treatment and check if new drugs are working.

However, there is a big problem — money. Research takes a lot of time and funding, and Arnsten warns that budget cuts to the U.S. National Institutes of Health (NIH) could stop many projects. She said her lab has found a promising compound that might block early brain damage, but they cannot move forward without more funding. If this research stops now, she warned, many families will lose hope. Alzheimer’s already costs governments massive amounts in care, so cutting research would be a costly mistake. For now, scientists are still working, but they say the world must act fast — because every year, more people face this disease.